For the past 15 years Dr. Saag has devoted the majority of his career efforts to patient-oriented research in pharmacoepidemiology (drug safety and comparative effectiveness) research and evidence implementation (a branch of outcomes or Type 2 translational) research of the rheumatic diseases. In addition to competing successfully for peer reviewed funding, including the third renewal of his AHRQ supported Center for Education and Research on Therapeutics (CERTs) of musculoskeletal disorders, Dr. Saag has published or has in press 119 original scientific reports (75 with mentees as authors). Since the award of his K24 in 2005, Dr. Saag has served as a primary or secondary mentor for 22 pre and post- doctoral trainees. Along with his work as director of the CERTs, Dr. Saag's mentoring is facilitated by his role as director of the UAB Center for Outcomes, Effectiveness Research and Education and its T32 Health Services Research Training Grant. Renewal of his K24 grant would preserve Dr. Saag's protected time at 50% or greater effort and relieve future clinical and administrative responsibilities. Research proposed includes 3 current projects, 3 new projects and 4 future projects addressing novel questions about biologics agent safety in adults and children with inflammatory arthritis;evidence implementation research in osteoporosis;pharmacoepidemiology of osteoporosis examining adherence, comparative effectiveness, and bisphosphonate safety;and gout epidemiology. All the research proposed provide mentoring opportunities and make use of currently available large datasets, including national Medicare/Medicaid data. Dr. Saag will continue to recruit two or three new trainees into his research program each year, expand and refine his formal mentoring program using feedback received from trainees, and extend his leadership role in mentoring through the UAB Clinical &Translational Science Award (CTSA). UAB, its Schools, Departments, Divisions, and Interdisciplinary Research Centers provide an outstanding environment for the development of junior investigators in patient-oriented research. Based on institutional commitment and resources and Dr. Saag's successful record in research and mentoring, the renewal of Dr. Saag's K24 will maintain and greatly augment his ability to expand his research program aimed at developing the next generation of patient-oriented clinical investigators.

Public Health Relevance

During the past 15 years, Dr. Kenneth Saag has conducted funded patient-oriented research in the areas of drug safety, comparative effectiveness, and evidence implementation while engaged in mentoring the next generation of patient-oriented clinical investigators. Dr. Saag's research and mentoring opportunities are enhanced by his leadership with national research and mentoring organizations. Based on strong institutional commitment and resources as well as his success in training academic clinical researchers, a renewal of his K24 will maintain and expand his research and mentoring activities.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Witter, James
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Edmonds, Stephanie W; Cram, Peter; Lou, Yiyue et al. (2016) Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. BMC Musculoskelet Disord 17:369
Danila, Maria I; Outman, Ryan C; Rahn, Elizabeth J et al. (2016) A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material. Contemp Clin Trials Commun 4:14-24
Yun, Huifeng; Xie, Fenglong; Delzell, Elizabeth et al. (2015) Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Ann Rheum Dis 74:1065-71
Zhang, Jie; Xie, Fenglong; Delzell, Elizabeth et al. (2015) Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 67:624-32
Curtis, J R; Yang, S; Patkar, N M et al. (2014) Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken) 66:990-7
Warriner, Amy H; Outman, Ryan C; Feldstein, Adrianne C et al. (2014) Effect of self-referral on bone mineral density testing and osteoporosis treatment. Med Care 52:743-50
Herrinton, Lisa J; Harrold, Leslie R; Liu, Liyan et al. (2013) Association between anti-TNF-α therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf 22:394-402
Warriner, Amy H; Saag, Kenneth G (2013) Osteoporosis diagnosis and medical treatment. Orthop Clin North Am 44:125-35
Curtis, Jeffrey R; Sharma, Pradeep; Arora, Tarun et al. (2013) Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System. Arthritis Care Res (Hoboken) 65:235-43
Teng, Gim Gee; Tan, Chuen Seng; Santosa, Amelia et al. (2013) Serum urate levels and consumption of common beverages and alcohol among Chinese in Singapore. Arthritis Care Res (Hoboken) 65:1432-40

Showing the most recent 10 out of 47 publications